PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our dedicated team of about 11,000 employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics and discovery and analytical solutions markets.
PerkinElmer’s comprehensive portfolio of technologies helps life sciences researchers better understand diseases and develop treatments.
Scientists and clinicians can gain biological insights to improve outcomes through our discovery instruments and reagents, quantitative pathology platform, informatics software and lab services.
Our technologies and expertise have been instrumental in the development of 22 of the newest therapeutic drugs.
PerkinElmer’s Operetta CLS™ high-content analysis system enables scientists to uncover deep biological understanding from everyday assays and innovative applications. The system features a unique combination of technologies to deliver the speed, sensitivity and resolution needed to reveal fine subcellular details.
The Opera Phenix™ high-content screening system is designed for high-throughput phenotypic screening and cellular analysis and is ideal for complex disease models such as live cells, primary cells and 3D cell culture models.
Find out how PerkinElmer high-content analysis solutions allow robust and predictive discovery by visiting: